Humoral immunostimulation. IV. Role of complement.
Open Access
- 1 April 1975
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 141 (4) , 736-752
- https://doi.org/10.1084/jem.141.4.736
Abstract
When L cells were treated with anti-L-cell antibody in medium containing heat-inactivated fetal calf serum, nucleoside uptake and cell growth were stimulated. The response was markedly increased when fresh, unheated sera from calves, guinea pigs, humans, mice, or rabbits were also present. The factors in unheated serum responsible for the enhancement of immunostimulation were studied. Using low concentrations of sera deficient in various complement (C) components and low concentrations of antibody no augmentation of immunostimulation was seen with Clr-deficient human serum, C2-deficient human serum, C2,4-deficient human serum, C4-deficient guinea pig serum, C3-C9-depleted guinea pig serum (by administration of cobra venom factor to animals), but stimulation was observed with C5-deficient human serum, C5-deficient mouse serum, and C6-deficient rabbit serum. When the concentration of anti-serum was raised, however, augmentation was observed with C4-deficient guinea pig serum. Thus, at low concentrations of antiserum enhancement appeared to occur through the classical C pathway, whereas at high concentrations of antibody either the classical or alternate C pathways appeared to be involved. Stimulation was specifically restored by purified C2 in C2-deficient serum and by C3 in C3-C9-deficient serum. Under the usual reaction conditions consumption of guinea pig C component C4 could be demonstrated which provided direct evidence for activation of the classical C pathway under conditions leading to immunostimulation. By immunofluorescence, cells treated with antibody and normal human serum had human C3 deposited at the cell surface. Taken together these observations suggest that C activated through C3 by either the classical or alternate pathways has the potential to enhance nucleoside incorporation into DNA and cell growth of cells exposed to limiting amounts of antibody. Although the mechanism of stimulation is unknown, it is likely to involve a direct effect of C3 at the level of the cell membrane.Keywords
This publication has 29 references indexed in Scilit:
- RECEPTOR FOR SOLUBLE C3 AND C3b ON HUMAN LYMPHOBLASTOID (RAJI) CELLSThe Journal of Experimental Medicine, 1974
- HUMORAL IMMUNOSTIMULATIONThe Journal of Experimental Medicine, 1974
- Stimulation of Cells by AntibodyScience, 1973
- Bound C3 as the second signal for B-cell activationCellular Immunology, 1973
- Involvement of proteolytic activity in early events in lymphocyte transformation by phytohemagglutininBiochemical and Biophysical Research Communications, 1973
- A New Complement-Mediated Cytolytic Mechanism—the C1-Bypass Activation PathwayProceedings of the National Academy of Sciences, 1973
- The Complement System of ManNew England Journal of Medicine, 1972
- Immune Hemolysis: A Simplified Method for the Preparation of EaC′4 with Guinea Pig or with Human ComplementThe Journal of Immunology, 1967
- DEFICIENCY OF THE SIXTH COMPONENT OF COMPLEMENT IN RABBITS WITH AN INHERITED COMPLEMENT DEFECTThe Journal of Experimental Medicine, 1966
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965